Compare PE-22-28 (evidence D) and Pinealon (evidence D) on mechanism, clinical status, safety, and dosing.
PE-22-28 is a 7-amino-acid peptide derived from a truncation of spadin, a natural peptide fragment of the sortilin propeptide. It acts as an antagonist of the…
Pinealon (Glu-Asp-Arg, EDR) is a synthetic tripeptide (MW ~418 g/mol) developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and…